Katz S P, Colley D G
Infect Immun. 1976 Aug;14(2):502-8. doi: 10.1128/iai.14.2.502-508.1976.
The development of immunological responsiveness to a soluble cercarial antigenic preparation (CAP) from Schistosoma mansoni was analyzed in inbred CBA/J mice infected with cercariae, one or multiple times, or sensitized using CAP. Repeated exposure to 75 cercariae at three weekly intervals (3X-75) or subcutaneous administration of 20 mug of CAP (CAP/complete Freund adjuvant [CFA]) stimulated the development of specific anti-CAP lymph node cell blastogenesis. The degree of responsiveness was dependent upon the concentration of CAP in the culture system and was optimal in the dose range of 20 to 30 mug of protein of CAP per culture. Animals exposed once to 75 or 225 cercariae or to two sequential weekly infections with 75 cercariae exhibited a minimal response to CAP in comparison to the responsiveness of 3X-75 or CAP/CFA lymph node cells. Assessment of anti-CAP agglutinating antibody by application of a microtiter passive hemagglutination technique revealed that both 3X-75 and CAP/CFA animals possessed low titers of activity. In addition, both 3X-75 and CAP/CFA sera contained reagin-like antibodies to CAP as detected by the heterologous (rat), 72-h latent period, passive cutaneous anaphylaxis technique.
在感染曼氏血吸虫尾蚴一次或多次的近交系CBA/J小鼠中,或使用可溶性尾蚴抗原制剂(CAP)致敏的小鼠中,分析了对曼氏血吸虫可溶性尾蚴抗原制剂(CAP)的免疫反应性发展情况。每隔三周重复暴露于75条尾蚴(3X-75)或皮下注射20微克CAP(CAP/完全弗氏佐剂 [CFA])刺激了特异性抗CAP淋巴结细胞的增殖。反应程度取决于培养系统中CAP的浓度,在每培养物20至30微克CAP蛋白的剂量范围内最佳。与3X-75或CAP/CFA淋巴结细胞的反应性相比,单次暴露于75或225条尾蚴或连续两周每周感染75条尾蚴的动物对CAP的反应最小。通过微量滴定被动血凝技术评估抗CAP凝集抗体发现,3X-75和CAP/CFA动物的活性滴度都很低。此外,通过异源(大鼠)、72小时潜伏期、被动皮肤过敏反应技术检测发现,3X-75和CAP/CFA血清中都含有针对CAP的反应素样抗体。